According to our (Global Info Research) latest study, the global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market size was valued at US$ 395 million in 2025 and is forecast to a readjusted size of US$ 1680 million by 2032 with a CAGR of 22.8% during review period.
In 2025, global sales of Joule-Thomson throttling refrigeration cryoablation devices reached 476 units, with an average price of $806,000 per unit.
Cryoablation refers to a method of freezing diseased tissue through low-temperature technology to achieve in situ inactivation of solid tissue. The working principle is to use low temperature to quickly cool down the diseased tissue to destroy cells, causing cell necrosis or apoptosis, thereby achieving the purpose of treatment. Since cryoablation uses the physical method of energy exchange to achieve the purpose of treatment, its trauma and side effects to the human body are much lower than conventional radiotherapy and chemotherapy, so it is hailed as a "green therapy".
In the 1990s, Endocare, an American company, developed a new type of cryotherapy equipment using the Joule-Thomson throttling refrigeration principle. The equipment uses argon throttling refrigeration and helium throttling heating rewarming to achieve rapid freezing treatment and rewarming needle removal. It is used for ablation treatment of various solid tumors such as lung cancer and liver cancer. China has become the most active country in the world in clinical research on cryoablation tumors.
The raw material system for these devices falls into two main categories: the main unit and single-use consumables. Core components of the main unit include a high-precision gas control system (pressure sensors, flow control valves, and solenoid valve assemblies), a touchscreen control unit, vacuum-insulated gas transmission lines, and an aluminum alloy or stainless steel chassis frame. The gas control valve assemblies and sensors require extremely high precision in manufacturing; manufacturers often employ a single-supplier strategy to meet FDA, CE, and NMPA regulatory requirements. As the core consumable, the cryoablation needle comprises materials such as the needle tip (Inconel 625 nickel-chromium alloy for MRI-compatible versions; AISI 316L stainless steel for non-MRI versions), polyurethane catheters, polyoxymethylene (POM) connectors, vacuum insulation materials, and sterile packaging. Additionally, the system requires high-pressure argon and helium cylinders along with pressure-reducing adapters to supply the refrigerants.
Regarding cost structure, this type of equipment follows a classic "razor-and-blade" business model. Although the main unit sells for hundreds of thousands of dollars, profits are primarily derived from the high-margin single-use cryoablation needles. The end-user price for a needle ranges from approximately 8,000 to 18,800 RMB, while raw material costs (metal needle tubes, polymer catheters, insulation materials, etc.) account for only 10–20% of the selling price. Major cost drivers include precision manufacturing processes (complex procedures such as vacuum-exhaust welding and stepped-hole sealing), investment in sterile production environments, regulatory compliance costs for Class III medical devices (registration, clinical validation, and quality systems), and the amortization of R&D expenses for novel intelligent temperature control algorithms. In terms of the cost breakdown for the main unit, electronic control systems account for approximately 30–40%, precision gas piping for 20–25%, software systems for 15–20%, and the chassis structure for 10–15%. As many key components rely on single-source suppliers, supply chain risk is high; upstream capacity constraints or quality issues can directly impact the production of the complete unit and clinical supply.
This report is a detailed and comprehensive analysis for global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific (US), Metrum Cryoflex (PL), Siemens (DE), ERBE Elektromedizin (DE), AccuTarget MediPharma (CN), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Liquid Nitrogen
Argon and Helium
Carbon Dioxide and Nitrous Oxide
Others
Market segment by Probe Diameter
1.3-1.5mm
1.7mm
2.4-3.5mm
Market segment by Treatment Method
Percutaneous Puncture
Laparoscopic/Endoscopic
Market segment by Application
Tumor Treatment
Heart Treatment
Others
Major players covered
Boston Scientific (US)
Metrum Cryoflex (PL)
Siemens (DE)
ERBE Elektromedizin (DE)
AccuTarget MediPharma (CN)
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device, with price, sales quantity, revenue, and global market share of Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device from 2021 to 2026.
Chapter 3, the Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device.
Chapter 14 and 15, to describe Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device. Industry analysis & Market Report on Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device is a syndicated market report, published as Global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.